The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le, Y.
Right arrow Articles by Wang, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le, Y.
Right arrow Articles by Wang, J. M.
The Journal of Immunology, 2001, 166: 1448-1451.
Copyright © 2001 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: The Neurotoxic Prion Peptide Fragment PrP106–126 Is a Chemotactic Agonist for the G Protein-Coupled Receptor Formyl Peptide Receptor-Like 11 ,2

Yingying Le*, Hiroshi Yazawa*, Wanghua Gong{dagger}, Zuxi Yu{ddagger}, Victor J. Ferrans{ddagger}, Philip M. Murphy§ and Ji Ming Wang3,*

* Laboratory of Molecular Immunoregulation, Division of Basic Sciences, National Cancer Institute-Frederick and {dagger} Intramural Research Support Program, Science Applications International Corporation-Frederick, Frederick, MD 21702; {ddagger} Pathology Section, National Heart, Lung and Blood Institute and § Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892

Prion diseases are transmissible and fatal neurodegenerative disorders which involve infiltration and activation of mononuclear phagocytes at the brain lesions. A 20-aa acid fragment of the human cellular prion protein, PrP106–126, was reported to mimic the biological activity of the pathologic isoform of prion and activates mononuclear phagocytes. The cell surface receptor(s) mediating the activity of PrP106–126 is unknown. In this study, we show that PrP106–126 is chemotactic for human monocytes through the use of a G protein-coupled receptor formyl peptide receptor-like 1 (FPRL1), which has been reported to interact with a diverse array of exogenous or endogenous ligands. Upon stimulation by PrP106–126, FPRL1 underwent a rapid internalization and, furthermore, PrP106–126 enhanced monocyte production of proinflammatory cytokines, which was inhibited by pertussis toxin. Thus, FPRL1 may act as a "pattern recognition" receptor that interacts with multiple pathologic agents and may be involved in the proinflammatory process of prion diseases.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
C. Lin, W. Wei, J. Zhang, S. Liu, Y. Liu, and D. Zheng
Formyl peptide receptor-like 1 mediated endogenous TRAIL gene expression with tumoricidal activity
Mol. Cancer Ther., October 1, 2007; 6(10): 2618 - 2625.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Miao, B. A. Premack, Z. Wei, Y. Wang, C. Gerard, H. Showell, M. Howard, T. J. Schall, and R. Berahovich
Proinflammatory Proteases Liberate a Discrete High-Affinity Functional FPRL1 (CCR12) Ligand from CCL23
J. Immunol., June 1, 2007; 178(11): 7395 - 7404.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Prat, J. Bestebroer, C. J. C. de Haas, J. A. G. van Strijp, and K. P. M. van Kessel
A New Staphylococcal Anti-Inflammatory Protein That Antagonizes the Formyl Peptide Receptor-Like 1
J. Immunol., December 1, 2006; 177(11): 8017 - 8026.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
J. Murali and R. Jayakumar
Lymphocyte toxicity of prion fragments.
J. Biochem., March 1, 2006; 139(3): 329 - 338.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. J. G. de Almeida, L. B. Chiarini, J. P. da Silva, P. M. R. e Silva, M. A. Martins, and R. Linden
The cellular prion protein modulates phagocytosis and inflammatory response
J. Leukoc. Biol., February 1, 2005; 77(2): 238 - 246.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. de Paulis, N. Montuori, N. Prevete, I. Fiorentino, F. W. Rossi, V. Visconte, G. Rossi, G. Marone, and P. Ragno
Urokinase Induces Basophil Chemotaxis through a Urokinase Receptor Epitope That Is an Endogenous Ligand for Formyl Peptide Receptor-Like 1 and -Like 2
J. Immunol., November 1, 2004; 173(9): 5739 - 5748.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q. Chen, D. Wade, K. Kurosaka, Z. Y. Wang, J. J. Oppenheim, and D. Yang
Temporin A and Related Frog Antimicrobial Peptides Use Formyl Peptide Receptor-Like 1 as a Receptor to Chemoattract Phagocytes
J. Immunol., August 15, 2004; 173(4): 2652 - 2659.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-S. Bae, H. Y. Lee, E. J. Jo, J. I. Kim, H.-K. Kang, R. D. Ye, J.-Y. Kwak, and S. H. Ryu
Identification of Peptides That Antagonize Formyl Peptide Receptor-Like 1-Mediated Signaling
J. Immunol., July 1, 2004; 173(1): 607 - 614.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. de Paulis, N. Prevete, I. Fiorentino, A. F. Walls, M. Curto, A. Petraroli, V. Castaldo, P. Ceppa, R. Fiocca, and G. Marone
Basophils Infiltrate Human Gastric Mucosa at Sites of Helicobacter pylori Infection, and Exhibit Chemotaxis in Response to H. pylori-derived Peptide Hp(2-20)
J. Immunol., June 15, 2004; 172(12): 7734 - 7743.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Ying, P. Iribarren, Y. Zhou, W. Gong, N. Zhang, Z.-X. Yu, Y. Le, Y. Cui, and J. M. Wang
Humanin, a Newly Identified Neuroprotective Factor, Uses the G Protein-Coupled Formylpeptide Receptor-Like-1 as a Functional Receptor
J. Immunol., June 1, 2004; 172(11): 7078 - 7085.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
B. McMahon and C. Godson
Lipoxins: endogenous regulators of inflammation
Am J Physiol Renal Physiol, February 1, 2004; 286(2): F189 - F201.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Partida-Sanchez, P. Iribarren, M. E. Moreno-Garcia, J.-L. Gao, P. M. Murphy, N. Oppenheimer, J. M. Wang, and F. E. Lund
Chemotaxis and Calcium Responses of Phagocytes to Formyl Peptide Receptor Ligands Is Differentially Regulated by Cyclic ADP Ribose
J. Immunol., February 1, 2004; 172(3): 1896 - 1906.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Marella and J. Chabry
Neurons and Astrocytes Respond to Prion Infection by Inducing Microglia Recruitment
J. Neurosci., January 21, 2004; 24(3): 620 - 627.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. E. VanCompernolle, K. L. Clark, K. A. Rummel, and S. C. Todd
Expression and Function of Formyl Peptide Receptors on Human Fibroblast Cells
J. Immunol., August 15, 2003; 171(4): 2050 - 2056.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. M. Bacot, P. Lenz, M. R. Frazier-Jessen, and G. M. Feldman
Activation by prion peptide PrP106-126 induces a NF-{kappa}B-driven proinflammatory response in human monocyte-derived dendritic cells
J. Leukoc. Biol., July 1, 2003; 74(1): 118 - 125.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
Y. Cui, Y. Le, H. Yazawa, W. Gong, and J. M. Wang
Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease
J. Leukoc. Biol., October 1, 2002; 72(4): 628 - 635.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Mitchell, G. Thomas, K. Harvey, D. Cottell, K. Reville, G. Berlasconi, N. A. Petasis, L. Erwig, A. J. Rees, J. Savill, et al.
Lipoxins, Aspirin-Triggered Epi-Lipoxins, Lipoxin Stable Analogues, and the Resolution of Inflammation: Stimulation of Macrophage Phagocytosis of Apoptotic Neutrophils In Vivo
J. Am. Soc. Nephrol., October 1, 2002; 13(10): 2497 - 2507.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. Yang, Q. Chen, B. Gertz, R. He, M. Phulsuksombati, R. D. Ye, and J. J. Oppenheim
Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation
J. Leukoc. Biol., September 1, 2002; 72(3): 598 - 607.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Bylund, A. Karlsson, F. Boulay, and C. Dahlgren
Lipopolysaccharide-Induced Granule Mobilization and Priming of the Neutrophil Response to Helicobacter pylori Peptide Hp(2-20), Which Activates Formyl Peptide Receptor-Like 1
Infect. Immun., June 1, 2002; 70(6): 2908 - 2914.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-H. Cui, Y. Le, W. Gong, P. Proost, J. Van Damme, W. J. Murphy, and J. M. Wang
Bacterial Lipopolysaccharide Selectively Up-Regulates the Function of the Chemotactic Peptide Receptor Formyl Peptide Receptor 2 in Murine Microglial Cells
J. Immunol., January 1, 2002; 168(1): 434 - 442.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Della-Bianca, F. Rossi, U. Armato, I. Dal-Pra, C. Costantini, G. Perini, V. Politi, and G. Della Valle
Neurotrophin p75 Receptor Is Involved in Neuronal Damage by Prion Peptide-(106-126)
J. Biol. Chem., October 12, 2001; 276(42): 38929 - 38933.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Christophe, A. Karlsson, C. Dugave, M.-J. Rabiet, F. Boulay, and C. Dahlgren
The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2
J. Biol. Chem., June 8, 2001; 276(24): 21585 - 21593.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.